Northrop Grumman (NOC) Dips 2% Despite Q1 Beat — Analysts Project 29% Rally Ahead

Key Takeaways

• NOC declined approximately 2% following Q1 results even though the company surpassed EPS expectations with $6.14 versus the anticipated $6.03, while revenue reached $9.88 billion, representing a 4.4% year-over-year increase
• The Aeronautics division experienced a 17% revenue surge, primarily fueled by the B-21 Raider stealth bomber transitioning into low-rate initial production phase
• The U.S. Air Force has approved a 25% expansion in annual B-21 manufacturing capacity
• The company maintains a robust $96 billion order backlog, alongside plans to invest $2.5 billion in B-21 production facilities by 2029
• Analyst consensus points to a Moderate Buy recommendation, with a mean price target of $743.33, suggesting approximately 29% potential upside

Northrop Grumman (NOC) delivered first-quarter results on April 21 that exceeded Wall Street expectations, yet shares retreated roughly 2% in response. While the initial market reaction might seem puzzling, a closer examination reveals some underlying concerns.

Northrop Grumman Corporation, NOC

The defense contractor posted adjusted earnings per share of $6.14, topping analyst forecasts of $6.03. Total revenue came in at $9.88 billion, marking a 4.4% improvement compared to the prior-year period and exceeding the Street’s $9.75 billion projection. By conventional metrics, this represents a successful quarter.

Market participants appear to be reacting to an upward revision in 2026 capital expenditure guidance by $200 million, combined with a $71 million negative adjustment in the Space division connected to the GEM 63XL program. While neither development is particularly alarming, they caught investor attention.

The Aeronautics business unit emerged as the quarterly star performer. Revenue surged 17%, primarily attributed to the B-21 Raider entering its low-rate initial production stage. Segment margins rebounded to 9.3%, benefiting partly from the absence of loss charges that impacted the beginning of 2025.

Additionally, the Air Force has approved a 25% increase in B-21 annual production capacity. This represents tangible evidence of sustained demand rather than mere speculation.

The Defense Systems segment posted 5% sales growth, with the Sentinel intercontinental ballistic missile program continuing its upward trajectory. Mission Systems revenue remained essentially flat, though operating income jumped 20%, supported by beneficial contract modifications.

B-21 Expansion Strengthens Revenue Pipeline

Company leadership indicated plans to deploy $2.5 billion in internal capital toward B-21 production infrastructure through 2029. Over the past two years, Northrop has inaugurated more than 20 new manufacturing facilities, demonstrating its commitment to scaling capacity for anticipated demand.

The order backlog currently stands at $96 billion, representing approximately two to three years of secured future revenue. Full-year 2026 EPS guidance was established at $27.40 to $27.90, which management maintained essentially unchanged following the quarterly report.

Shares are presently valued at roughly 21 times the 2026 consensus EPS estimate of $27.93. The stock has traded between $453.01 and $774.00 over the past 52 weeks, with NOC beginning Monday’s session at $575.57—trading below both its 50-day moving average of $699.43 and its 200-day average of $638.36.

Wall Street Maintains Constructive Outlook

Vanguard Group expanded its NOC holdings by 1.5% during the fourth quarter, elevating its ownership to approximately 9.63% of outstanding shares.

Regarding analyst coverage, Royal Bank of Canada elevated its price objective to $750 while maintaining an Outperform rating. Deutsche Bank holds a Buy recommendation with a $765 target. UBS reduced its target from $806 to $745 but preserved its Buy stance. Citigroup similarly lowered its target from $807 to $742 while keeping a Buy rating. Jefferies shifted to a Hold position.

The Street consensus stands at Moderate Buy, supported by 10 Buy recommendations and five Hold ratings. Currently, no analyst maintains a Sell rating on NOC. The average price objective of $743.33 suggests roughly 29% appreciation potential from present valuation levels.

The company also announced a quarterly dividend of $2.31 per share, distributed on March 11, translating to an annualized payment of $9.24 and yielding 1.6%.

The latest insider transaction involved CAO Michael Hardesty divesting 147 NOC shares at $732.98 each on February 19.

The post Northrop Grumman (NOC) Dips 2% Despite Q1 Beat — Analysts Project 29% Rally Ahead appeared first on Blockonomi.